Insider screener

Period: 12 months Type of trade: Sold × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

46,134 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

46,134 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

46,134 decisions over 12 months Remove this filter
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

46,134 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
46,134 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
46,134 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

46,134 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
10 Mar 2026
Sold at will
$383.58K 6,633 at 57.83
50.2%
Sold half or more
10 Mar 2026
Eng Julie Sheridan Chief Technology Officer
Sold on a plan
$375.39K 1,454 at 258.18
2.9%
Planned (10b5-1)
10 Mar 2026
Slootman Frank Director
Sold on a plan
$372.54K 2,042 at 182.44
4.1%
Planned (10b5-1)
10 Mar 2026
Levie Aaron Chief Executive Officer
Sold on a plan
$370.82K 15,000 at 24.72
0.5%
Planned (10b5-1)
10 Mar 2026
Arora Tarun Chief Accounting Officer
Sold on a plan
$359.66K 8,840 at 40.69
10.5%
Planned (10b5-1)
10 Mar 2026
RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER
Sold on a plan
$356.21K 1,745 at 204.13
0.7%
Planned (10b5-1)
10 Mar 2026
Rothka John Chief Accounting Officer
Sold at will
$348.16K 3,800 at 91.62
38.0%
Not planned
10 Mar 2026
Wu Bor-Tay VP, Taiwan Operations
Sold at will
$346.54K 40,000 at 8.66
4.2%
Not planned
10 Mar 2026
Cohen Marc Eliot Group Managing Director
Sold at will
$337.04K 1,088 at 309.72
19.8%
Not planned
10 Mar 2026
Baker Jeff Principal Accounting Officer
Sold at will
$334.98K 4,500 at 74.44
10.9%
Not planned
10 Mar 2026
May Scarlett EVP, GENERAL COUNSEL
Sold at will
$327.71K 5,206 at 62.95
16.8%
Not planned
10 Mar 2026
Pearce Sheri See Remarks
Sold at will
$318.64K 14,000 at 22.76
12.3%
Not planned
10 Mar 2026
LINK EDWARD J. VP, Information Technology
Sold at will
$310.65K 1,275 at 243.64
4.3%
Not planned
10 Mar 2026
Nyce Chad D EVP & Chief Operating Officer
Sold at will
$308.43K 8,450 at 36.50
4.6%
Not planned
10 Mar 2026
Collins Helen Louise CHIEF MEDICAL OFFICER
Sold on a plan
$305.83K 10,129 at 30.19
28.8%
Planned (10b5-1)
10 Mar 2026
Humphrey Heather A SVP - GEN COUNSEL, CORP SEC
Sold at will 2×
$301.53K 3,650 at 82.61
7.7%
Not planned
10 Mar 2026
Trefler Leon Chief of Clients and Markets
Sold at will
$299.86K 6,700 at 44.76
5.4%
Not planned
10 Mar 2026
Farquhar John C.M. Chief Executive Officer
Sold on a plan
$290.89K 12,837 at 22.66
2.2%
Planned (10b5-1)
10 Mar 2026
Sold at will
$290.25K 75,000 at 3.87
9.2%
Not planned
10 Mar 2026
Santana Rafael President and CEO
Sold on a plan 6×
$289.39K 1,163 at 248.83
0.6%
Planned (10b5-1)
10 Mar 2026
RUBINSTEIN JULIE President and COO
Sold on a plan
$285.67K 19,460 at 14.68
2.9%
Planned (10b5-1)
10 Mar 2026
Hanstveit Arve Director
Sold at will
$273.98K 25,000 at 10.96
4.3%
Not planned
10 Mar 2026
Semah Victor Chief Legal Officer
Sold on a plan
$269.69K 5,498 at 49.05
18.1%
Planned (10b5-1)
10 Mar 2026
Kirscht Patrick Chief Credit Officer
Sold at will 4×
$266.07K 54,299 at 4.90
11.0%
Not planned
10 Mar 2026
Susi Roger E. CEO, PRESIDENT, CHAIRMAN · indirect
Sold at will
$250.28K 2,500 at 100.11
0.1%
Not planned
10 Mar 2026
Horich William Todd SVP, Commercial Operations
Sold at will
$244.15K 4,439 at 55.00
100%
Sold half or more
10 Mar 2026
TOTH A ERNEST JR Chief Financial Officer
Sold at will
$243.09K 58,254 at 4.17
13.4%
Not planned
10 Mar 2026
Buch Anand Chief Strategy Officer
Sold at will 2×
$238.03K 34,315 at 6.94
6.0%
Not planned
10 Mar 2026
Lin Mark EVP and CFO
Sold on a plan
$233.13K 2,734 at 85.27
8.2%
Planned (10b5-1)
10 Mar 2026
Raiford Daryl E Chief Financial Officer
Sold at will
$228.40K 14,000 at 16.31
15.1%
Not planned
10 Mar 2026
Glennan Sean Joseph Chief Financial Officer
Sold on a plan
$226.87K 4,625 at 49.05
27.7%
Planned (10b5-1)
10 Mar 2026
KUEHN KURT P Director
Sold at will
$224.57K 2,844 at 78.96
15.6%
Not planned
10 Mar 2026
Desale Pravin SVP, R&D
Sold at will
$218.64K 2,366 at 92.41
2.8%
Not planned
10 Mar 2026
Datar Srikant M. Director · indirect
Sold at will
$218.25K 1,000 at 218.25
8.4%
Not planned
10 Mar 2026
Lucas Shannon President & COO · indirect
Sold on a plan
$208.26K 11,700 at 17.80
0.7%
Planned (10b5-1)
10 Mar 2026
Sankarlingam Velchamy Pres. of Engineering & Product
Sold on a plan
$202.64K 2,590 at 78.24
1.9%
Planned (10b5-1)
10 Mar 2026
Jung Cassie Chief Operating Officer
Sold at will
$191.09K 45,791 at 4.17
14.3%
Not planned
10 Mar 2026
Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS
Sold on a plan
$186.78K 915 at 204.13
0.6%
Planned (10b5-1)
10 Mar 2026
Ozuna Christina M. Chief Claims Officer
Sold at will
$179.46K 4,500 at 39.88
23.1%
Not planned
10 Mar 2026
Allison Jonathan Chief Administrative Officer
Sold on a plan
$175.38K 3,900 at 44.97
4.0%
Planned (10b5-1)
10 Mar 2026
TZIANABOS ARTHUR Interim Executive Chair
Sold on a plan
$174.21K 4,355 at 40.00
12.2%
Planned (10b5-1)
10 Mar 2026
Trimberger Lisa G Director · indirect
Sold at will
$172.15K 3,000 at 57.38
100%
Sold half or more
10 Mar 2026
BRAENDER LORI J Chief Legal Officer
Sold at will
$167.35K 40,102 at 4.17
8.3%
Not planned
10 Mar 2026
KENNEY CHRISTOPHER JOHN Chief Medical Officer
Sold on a plan
$166.56K 2,771 at 60.11
36.9%
Planned (10b5-1)
10 Mar 2026
Brophy Michael Burkes CHIEF FINANCIAL OFFICER
Sold on a plan
$160.24K 785 at 204.13
1.2%
Planned (10b5-1)
10 Mar 2026
Sold on a plan
$157.85K 333 at 474.01
2.3%
Planned (10b5-1)
10 Mar 2026
DiFabio Andrea Chief Legal Officer
Sold on a plan
$156.70K 2,607 at 60.11
34.8%
Planned (10b5-1)
10 Mar 2026
Sold at will
$156.58K 944 at 165.87
1.9%
Not planned
10 Mar 2026
Dowden Nathan J President & COO
Sold on a plan
$155.19K 11,894 at 13.05
5.7%
Planned (10b5-1)
10 Mar 2026
WENTWORTH KORY JAMES Chief Financial Officer
Sold on a plan
$148.22K 11,388 at 13.02
8.6%
Planned (10b5-1)
Showing 28,151–28,200 of 46,134. ← Newer Page 564 of 923 Older →